DSIR recognized | FWA approved-FWA00012971
 

CHAMPION Study

12 June, 2017 Uncategorized
UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction
Timeline: 2016-2017 (On Going)

Principal Investigator: Dr. Archana Patel, Dr. Vaishali Khedikar, Smita Puppalwar, Dr. Takshashila Taksande, Dr. Vaishali Shelekar, Poonam Dehenkar, Ashwini Pachare, Pushpa Iyangar, Madhurani Umate, Monali Chachere, Rupali Naik, Archana Sathawane.

Background Research Work: Postpartum haemorrhage (PPH) is defined as a blood loss of 500 mL or more within 24 hours of delivery, while severe PPH (sPPH) is defined as a blood loss of 1000 mL or more within the same time frame. PPH is the leading cause of maternal mortality in low-income countries and it contributes to nearly a quarter of maternal deaths globally. PPH is a significant contributor to severe maternal morbidity and long term disability, as well as to a number of other severe maternal conditions, generally associated with more substantial blood loss, including shock and organ dysfunction.
The majority of deaths due to PPH could be avoided through the use of prophylactic uterotonics during the third stage of labour and by timely and appropriate management. Oxytocin (Intramuscular/intravenous [IM/IV] 10 IU) is recommended as the uterotonic drug of choice.
Despite oxytocin being a well-known peptide hormone, there is limited information on its stability at tropical temperatures. The manufacturer recommends storage under refrigeration in most countries and there is general acknowledgement that cold storage would help to maintain quality of oxytocin especially in settings where it is difficult to obtain cold storage regularly.
Carbetocin appears to be a promising agent in the prevention of PPH. The clinical and pharmacological properties of carbetocin are similar to those of oxytocin.

Objective: The trial has two primary objectives:

  1. To evaluate non-inferiority of carbetocin RTS 100 μg IM versus oxytocin 10 IU IM after vaginal delivery in the prevention of the composite endpoint “blood loss of 500 mL or more or the use of additional uterotonics” at one hour and up to two hours for women who continue to bleed after one hour.
  2. To evaluate non-inferiority of carbetocin RTS 100 µg IM versus oxytocin 10 IU IM in the prevention of sPPH (≥1000 mL blood loss) at one hour and up to two hours for women who continue to bleed after one hour.

DISFIN Inauguration

12 June, 2017 News
DISFIN Inauguration

Diabetes in Sindhi families in Nagpur (DISFIN), an observational study was inaugurated. This study is being headed by Dr Manju Mamtani & Dr Hemant Kulkarni.

 

Dr.Sandeep Khanzode receives “Maitree Gaurav Puraskar”

15 March, 2017 News
Dr.Sandeep Khanzode receives “Maitree Gaurav Puraskar”

Dr.Sandeep Khanzode received the “Maitree Gaurav Puraskar-2016” for Medical field on 27 December 2016. Pictures attached below.

 

 

 

 

GN / RTI team’s site visit to LMRF 7-9th Nov.2016

2 December, 2016 Gallery
GN / RTI team’s site visit to LMRF 7-9th Nov.2016

 
 
 
 
 
 
 
 
 
 

CDC Site Visit to LMRF

2 December, 2016 News
CDC Site Visit to LMRF

CDC Site Visit to LMRF and  Dhruv Path Lab, Nagpur was conducted on November 17-18, 2016. Pictures below:
 
 
 
 
 
 
 

ASPIRIN coordinators training at Belagavi, India- 11th to 17th Nov’16

2 December, 2016 News, Uncategorized
ASPIRIN coordinators training at Belagavi, India- 11th to 17th Nov’16

ASPIRIN coordinators training was held at Belagavi, India from 11th to 17th November 2016. This training was attended by Dr.Prabirkumar Das from Lata Medical Research Foundation, Nagpur. Pictures below:

 
 
 
 
 

Awareness campaign under Lead Poisoning Prevention Week 23rd-29th Oct 2016

11 November, 2016 News
Awareness campaign under Lead Poisoning Prevention Week 23rd-29th Oct 2016

An awareness campaign under Lead Poisoning Prevention Week from 23rd to 29th October 2016 was conducted by Lata Medical Research Foundation, Nagpur. Images Below.
 
 
 
 
 
 
 

Training on Anthropometric Assessments for M-SAKHI study on 26th Oct.2016

11 November, 2016 News
Training on Anthropometric Assessments for  M-SAKHI study on 26th Oct.2016

Training on Anthropometric assessments for M-Sakhi study was held on 26th October 2016 by Lata Medical Research Foundation. Images below.
 
 
 
 
 
 
 

Carbetocin Study implementation training and study procedure overview at Belgaum, 27th- 29th Sept.2016

7 October, 2016 News
Carbetocin Study implementation training and study procedure overview at Belgaum, 27th- 29th Sept.2016

Carbetocin Study implementation training and study procedure overview at Belgaum, 27th- 29th Sept.2016. This training was attended by Dr.vaishali khedikar from LMRF, Dr.Sulbha Moon, Daga Memorial Hospital, Nagpur and Dr.Takshasheela Taksande  from LMRF, Nagpur.

Ganesh Festival at LMRF- Sept.2016

7 October, 2016 Gallery
Ganesh Festival at LMRF- Sept.2016